IndiaTickerEmmessar Biotech & Nutrition Ltd - 524768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Emmessar Biotech
BSE:EMMESSA · ISIN INE634B01016
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Emmessar Biotech
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Emmessar Biotech & Nutrition Ltd - 524768 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Newspaper Add On Relodgement Of SharesBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Newspaper Add For Financial Results For The Period Ended March 31, 2026BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Results For Perid Ended 31.03.2026BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Outcome for Audited Financial Results For Period Ended March 31, 2026BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Intimation for Approval Of Audited Results For Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Newspaper Add For Re-Lodgement Of Transfer
Requests Of Physical Shares Under Special WindowBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Newspaper AddBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Outcome for For Unaudited Results For December 31, 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Results- Financial For 31-12-2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended December 31, 2025.BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Newspaper AddBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended Sept 30, 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Results For Quarter Ended September 30, 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Intimation for Considering Unaudited Results For The Quarter Ended September 30, 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Newspaper Add For Completion Of Dispatch Of Annual ReportsBSE · annual report · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Notice Of The 33Rd Annual General Meeting To Be Held On Friday, 26Th September, 2025 At 10:30 A.M. (IST).BSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Newspaper Add - For Holding AGM Through VCBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Newspaper Add For Unaudited Financial Results For The Quarter Ended June 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Results For Quarter Ended June 30, 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For Quarter Ended June 30, 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Newspaper AddBSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Results For The Period Ended March 31, 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Outcome for Financial Results For The Period Ended March 31, 2025BSE · financial results · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Intimation for Consideration Of Audited Financial Results For The Period Ended March 31, 2025BSE · financial results · pdf
Source filing